Of the top 10 countries for health tech VC investment (between 2016-2021 YTD), the U.S. leads globally with $31.9 billion in VC investment so far this year, according to new research. In second place was China with $4.1 billion, while the U.K. comes in third with $3.8 billion. U.K. health tech investment has risen from just $420 million in 2016, an increase of nine times, whilst U.S. investment has increased by 3.4 times.
U.S.-based health tech companies continue to attract the lion’s share of global VC investment, clustered around the Bay Area, New York and Boston. Over the last two years investment has started to become more globally distributed, with investment less concentrated around the U.S. and China, said the research findings released by Dealroom.co for London & Partners.
U.K. health tech growth has traditionally been driven by the so-called “Golden Triangle” of London, Oxford and Cambridge, a region home to five universities in the top 25 for life sciences and medicine.
Europe is now the fastest-growing region globally for health tech according to the findings, with European health tech startups raising $8.1 billion in 2021, up from $1.7 billion in 2016 and growing at a rate of 4.9 times (compared to North America at 3.5x and Asia 3.7x).